Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

High-Dose Chemotherapy and Autologuos Stem Cell Transplantation in Previously Untreated Peripheral T-Cell Lymphoma - Final Analysis of a Large Prospective Multicenter Study (NLG-T-01)

Blood (2011) 118 (21): 331.

https://doi.org/10.1182/blood.V118.21.331.331

Published: 2011

Journal Articles

Increasing Grades of Follicular Lymphoma Correlate with Better Prognosis in Patients Treated with Rituximab

Björn Engelbrekt Wahlin, MD, PhD, Christer Sundström, Harald Holte, Birgitta Sander, MD, Ph.D., Bjørn Østenstad, Peter de Nully Brown, Erlend B. Smeland, Jan Delabie, Birger Christensson, M.D., Ph.D., Eva Kimby, M.D., Ph.D.

Blood (2011) 118 (21): 1641.

https://doi.org/10.1182/blood.V118.21.1641.1641

Published: 2011

Journal Articles

Mantle Cell Lymphoma Can Be Cured by Intensive Immunochemotherapy with In-Vivo Purged Stem-Cell Support; Final Report of the Nordic Lymphoma Group MCL2 Study.

Blood (2007) 110 (11): LB1.

https://doi.org/10.1182/blood.V110.11.LB1.lb1

Published: 2007

Journal Articles

Dose-Dense Induction Followed by Autologous Stem Cell Transplant (ASCT) as 1st Line Treatment in Peripheral T-Cell Lymphomas (PTCL) - A Phase II Study of the Nordic Lymphoma Group (NLG).

Blood (2006) 108 (11): 401.

https://doi.org/10.1182/blood.V108.11.401.401

Published: 2006

Journal Articles

Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to V H gene mutation status

Pawel Grabowski, Magnus Hultdin, Karin Karlsson, Gerard Tobin, Anna Åleskog, Ulf Thunberg, Anna Laurell, Christer Sundström, Richard Rosenquist, Göran Roos

Blood (2005) 105 (12): 4807–4812.

https://doi.org/10.1182/blood-2004-11-4394

Published: 2005

Journal Articles

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

Gerard Tobin, Ulf Thunberg, Karin Karlsson, Fiona Murray, Anna Laurell, Kerstin Willander, Gunilla Enblad, Mats Merup, Juhani Vilpo, Gunnar Juliusson, Christer Sundström, Ola Söderberg, Göran Roos, Richard Rosenquist

Blood (2004) 104 (9): 2879–2885.

https://doi.org/10.1182/blood-2004-01-0132

Published: 2004

Journal Articles

Chronic lymphocytic leukemias utilizing the V H 3-21 gene display highly restricted V λ 2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope

Gerard Tobin, Ulf Thunberg, Anna Johnson, Inger Eriksson, Ola Söderberg, Karin Karlsson, Mats Merup, Gunnar Juliusson, Juhani Vilpo, Gunilla Enblad, Christer Sundström, Göran Roos, Richard Rosenquist

Blood (2003) 101 (12): 4952–4957.

https://doi.org/10.1182/blood-2002-11-3485

Published: 2003

Journal Articles

Mutated V H genes and preferential V H 3-21 use define new subsets of mantle cell lymphoma

Blood (2003) 101 (10): 4047–4054.

https://doi.org/10.1182/blood-2002-11-3479

Published: 2003

Journal Articles

Somatically mutated Ig V H 3-21 genes characterize a new subset of chronic lymphocytic leukemia

Gerard Tobin, Ulf Thunberg, Anna Johnson, Ingrid Thörn, Ola Söderberg, Magnus Hultdin, Johan Botling, Gunilla Enblad, Jan Sällström, Christer Sundström, Göran Roos, Richard Rosenquist

Blood (2002) 99 (6): 2262–2264.

https://doi.org/10.1182/blood.V99.6.2262

Published: 2002

Journal Articles

CD38 expression is a poor predictor for V H gene mutational status and prognosis in chronic lymphocytic leukemia

Ulf Thunberg, Anna Johnson, Göran Roos, Ingrid Thörn, Gerard Tobin, Jan Sällström, Christer Sundström, Richard Rosenquist

Blood (2001) 97 (6): 1892–1894.

https://doi.org/10.1182/blood.V97.6.1892

Published: 2001

Journal Articles

Telomerase Activity in Hodgkin's Disease

Karl-Fredrik Norrback, Gunilla Enblad, Martin Erlanson, Christer Sundström, Göran Roos

Blood (1998) 92 (2): 567–573.

https://doi.org/10.1182/blood.V92.2.567

Published: 1998

Journal Articles

A Superantigen-Antibody Fusion Protein for T-Cell Immunotherapy of Human B-Lineage Malignancies

Cecilia Gidlöf, Mikael Dohlsten, Peter Lando, Terje Kalland, Christer Sundström, Thomas H. Tötterman

Blood (1997) 89 (6): 2089–2097.

https://doi.org/10.1182/blood.V89.6.2089

Published: 1997

NARROW

High-Dose Chemotherapy and Autologuos Stem Cell Transplantation in Previously Untreated Peripheral T-Cell Lymphoma - Final Analysis of a Large Prospective Multicenter Study (NLG-T-01)

Increasing Grades of Follicular Lymphoma Correlate with Better Prognosis in Patients Treated with Rituximab

Mantle Cell Lymphoma Can Be Cured by Intensive Immunochemotherapy with In-Vivo Purged Stem-Cell Support; Final Report of the Nordic Lymphoma Group MCL2 Study.

Dose-Dense Induction Followed by Autologous Stem Cell Transplant (ASCT) as 1st Line Treatment in Peripheral T-Cell Lymphomas (PTCL) - A Phase II Study of the Nordic Lymphoma Group (NLG).

Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to V H gene mutation status

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

Chronic lymphocytic leukemias utilizing the V H 3-21 gene display highly restricted V λ 2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope

Mutated V H genes and preferential V H 3-21 use define new subsets of mantle cell lymphoma

Somatically mutated Ig V H 3-21 genes characterize a new subset of chronic lymphocytic leukemia

CD38 expression is a poor predictor for V H gene mutational status and prognosis in chronic lymphocytic leukemia

Telomerase Activity in Hodgkin's Disease

A Superantigen-Antibody Fusion Protein for T-Cell Immunotherapy of Human B-Lineage Malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only